‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long – The Washington Post
- ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
- Daily pill can double survival time for world’s deadliest cancer, trial shows The Guardian
- Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program Le Monde.fr
- Daraxonrasib significantly extends survival in metastatic pancreatic cancer News-Medical
- RASolute 302 Brings a “Transformative” Moment in Pancreatic Cancer: A 60% Improvement in Overall Survival AJMC
المصدر: Google News — Pakistan / HEALTH
1
مشاهدة
